Dr. Rouzbeh Mostaedi, MD

Dr. Mostaedi practices at Addiction Medicine & Recovery Services at Oakland Medical Center in Oakland, California.

Dr. Mostaedi's NPI, 1366603862, was assigned on June 18, 2008. Dr. Mostaedi graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2008. Dr. Mostaedi's California license number on file is A110226.

Dr. Mostaedi's primary practice is Addiction Medicine & Recovery Services at Oakland Medical Center, at 380 West MacArthur Boulevard, Oakland, CA 94609. The practice phone is (510) 251-0121.

Dr. Mostaedi's primary practice is Addiction Medicine & Recovery Services at Oakland Medical Center in Oakland, California. Dr. Mostaedi is also affiliated with Oakland Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Mostaedi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mostaedi practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Mostaedi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Mostaedi is board certified in surgery by the American Board of Surgery. Dr. Mostaedi has a license on file in California.

Dmand AI lists acute gallbladder or bile duct inflammation, colon removal and gallbladder removal among the conditions Dr. Mostaedi treats.

CMS data shows 23 Medicare services from Dr. Mostaedi across 1 procedure code in 2016, for 18 Medicare patients. Medicare paid $759 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 18 Medicare patients who saw Dr. Mostaedi in 2024. 75% of them have high blood pressure, and 61% have chronic kidney disease. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mostaedi's median patient age at 52, with 73% women.

In 2024, Dr. Mostaedi wrote 209 Medicare Part D claims for 79 patients. 94% of them were for generic drugs. CMS names the drug for 126 of them, across 6 drugs with 11 or more claims each, at $1,807 in total drug cost. In 2023, CMS named 99 claims across 5 drugs.

Dr. Mostaedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mostaedi as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Mostaedi, published from 2023 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Hernia, Inguinal, Bariatric Surgery and Herniorrhaphy. Dr. Mostaedi has published most often in Hernia. Dr. Mostaedi's most frequent co-authors are Jie Yin, MD, Mohamed Reda Ali, MD and Brandon Cowan, MD.

CMS Open Payments shows 24 general payments to Dr. Mostaedi from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Intuitive Surgical, Inc. paid the most, $2,105.

Dmand AI lists 1 award for Dr. Mostaedi.

Dr. Mostaedi graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2008. Dr. Mostaedi is a member of ACS, ASMBS and SAGES.

Dr. Mostaedi is in network with 5 carriers, including Kaiser Permanente, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.